Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. May 7, 2009; 15(17): 2151-2155
Published online May 7, 2009. doi: 10.3748/wjg.15.2151
Published online May 7, 2009. doi: 10.3748/wjg.15.2151
Table 1 Patient characteristics and Jadad score of included trials
Trials | Number of patients (BB + I/EBL) | Mean age (yr) (BB + I/EBL) | Males (BB + I/EBL) | Follow-up duration (BB + I/EBL) | Child-Pugh (A:B:C) (BB + I/EBL) | EBL mean sessions | BB + ISMN (mg/d) | Jadad score |
Romero 2006 | 57/52 | 51 ± 10/53 ± 10 | 37:20/35:17 | 12/11.5 mo | 23:25:9/ 17:30:5 | 3.4 ± 1.2 | Nadolol 88 ± 68 5-ISMN 57.7 ± 27 | 6 |
PATCH 2002 | 51/51 | 50.7 ± 13.2/52.4 ± 13.4 | 35:16/35:16 | 248/356 d | 8:19:24/ 5:18:28 | 2 | Pronolol 80 (40-240) 5-ISMN | 5 |
LO 2002 | 61/60 | 51 ± 13/52 ± 12 | 47:14/46:14 | 24/25 mo | 13:35:13/13:35:12 | 3.3 ± 1.1 | Nadolol 48 ± 10 5-ISMN 30 ± 6 | 5 |
Villanueva 2001 | 72/72 | 60 ± 12/58 ± 14 | 43:29/47:25 | 20/22 mo | 19:39:14/11:43:18 | 2.1 | Nadolol 96 ± 56 5-ISMN 66 ± 22 | 6 |
- Citation: Ding SH, Liu J, Wang JP. Efficacy of β-adrenergic blocker plus 5-isosorbide mononitrate and endoscopic band ligation for prophylaxis of esophageal variceal rebleeding: A meta-analysis. World J Gastroenterol 2009; 15(17): 2151-2155
- URL: https://www.wjgnet.com/1007-9327/full/v15/i17/2151.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.2151